Literature DB >> 33343651

Pulmonary hypertension concurrent with pericardial effusion and superior vena cava syndrome: who is the initiator?

Bei-Ning Wang1, Yu-Xi Li2, Wei Ma2, Song-Yun Chu2, Zhi-Hao Liu2, Wen-Hui Ding2, Jian-Ping Li3.   

Abstract

Entities:  

Keywords:  Malignancy; Pericardial effusion; Pulmonary hypertension; Superior vena cava syndrome

Year:  2020        PMID： 33343651      PMCID： PMC7729177          DOI： 10.11909/j.issn.1671-5411.2020.11.010

Source DB:  PubMed          Journal:  J Geriatr Cardiol        ISSN： 1671-5411            Impact factor:   3.327


× No keyword cloud information.
  20 in total

Review 1.  Superior vena cava syndrome in thoracic malignancies.

Authors:  Philipp M Lepper; Sebastian R Ott; Hanno Hoppe; Christian Schumann; Uz Stammberger; Antonio Bugalho; Steffen Frese; Michael Schmücking; Norbert M Blumstein; Nicolas Diehm; Robert Bals; Jürg Hamacher
Journal:  Respir Care       Date:  2011-01-27       Impact factor: 2.258

Review 2.  Clinical practice. Superior vena cava syndrome with malignant causes.

Authors:  Lynn D Wilson; Frank C Detterbeck; Joachim Yahalom
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

Review 3.  Pericardial diseases in patients with cancer: contemporary prevalence, management and outcomes.

Authors:  Massimo Imazio; Marzia Colopi; Gaetano Maria De Ferrari
Journal:  Heart       Date:  2020-01-24       Impact factor: 5.994

Review 4.  Malignancy-related pericardial effusion. 127 cases from the Roswell Park Cancer Institute.

Authors:  J D Wilkes; P Fidias; L Vaickus; R P Perez
Journal:  Cancer       Date:  1995-10-15       Impact factor: 6.860

Review 5.  Pericardial Disease Associated with Malignancy.

Authors:  Ryan Schusler; Shari L Meyerson
Journal:  Curr Cardiol Rep       Date:  2018-08-20       Impact factor: 2.931

6.  Echo-guided pericardiocentesis in patients with clinically significant pericardial effusion. Outcomes over a 10-year period.

Authors:  S Akyuz; A Zengin; E Arugaslan; S Yazici; T Onuk; U S Ceylan; B Gungor; U Gurkan; T Kemaloglu Oz; H Kasikcioglu; N Cam
Journal:  Herz       Date:  2014-12-11       Impact factor: 1.443

7.  A structured, parsimonious approach to establish the cause of moderate-to-large pericardial effusion.

Authors:  Vikram Agarwal; Georges El Hayek; Patricia Chavez; Jose Ricardo Po; Eyal Herzog; Edgar Argulian
Journal:  Am J Cardiol       Date:  2014-05-17       Impact factor: 2.778

8.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

Review 9.  Superior vena cava syndrome: a contemporary review of a historic disease.

Authors:  Susan Cheng
Journal:  Cardiol Rev       Date:  2009 Jan-Feb       Impact factor: 2.644

10.  Causes and prognosis of symptomatic pericardial effusions treated by pericardiocentesis in an Asian academic medical centre.

Authors:  Xian Pei Cheong; Lawrence Ka Peng Law; Swee-Chong Seow; Lik Wui Edgar Tay; Huay Cheem Tan; Wee Tiong Yeo; Adrian F Low; Pipin Kojodjojo
Journal:  Singapore Med J       Date:  2019-07-11       Impact factor: 1.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.